James Page, MD
Orthopedic Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 057190 · 058496 · 059720 · 757662 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Page’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G37699 · Current
Licensed to practise in California · since 1978 · expires 2028-05-31 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$264,394
Medicare paid this office $264,394 for 468 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 327 | $60,826 | $115 |
| Replacement of knee joint, both sides of knee | 43 | $53,220 | $1,157 |
| Replacement of thigh bone and hip joint with prosthesis | 43 | $49,566 | $1,153 |
| Long return visit (40+ min) | 138 | $31,534 | $164 |
| Aspiration and/or injection of fluid from large joint | 102 | $10,794 | $69 |
See all 12 services
| Return visit (30+ min) | 327 | $60,826 | $115 |
| Replacement of knee joint, both sides of knee | 43 | $53,220 | $1,157 |
| Replacement of thigh bone and hip joint with prosthesis | 43 | $49,566 | $1,153 |
| Long return visit (40+ min) | 138 | $31,534 | $164 |
| Aspiration and/or injection of fluid from large joint | 102 | $10,794 | $69 |
| New patient visit (45+ min) | 73 | $10,213 | $140 |
| Injection of contrast for imaging of hip joint | 25 | $7,974 | $249 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 20 | $7,847 | None |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 37 | $7,070 | $186 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 44 | $3,788 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,729 | $155 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 94 | $427 | None |
Procedures Medicare counted
| Hip replacement | 42 | More than 84% of doctors who do this |
| Knee replacement | 51 | More than 79% of doctors who do this |
Who their Medicare patients are
468 Original Medicare patients in 2024. Average age 77 · Women 66% · Also on Medicaid 11% · Health risk score 0.92. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 72% · Diabetes 22% · Chronic kidney disease 21% · Coronary heart disease 18% · Cancer 18% · Atrial fibrillation 16% · Depression 16% · Heart failure 11% · COPD 8% · Stroke 6% · Dementia 4%.
The office billed $1,287,998, Medicare allowed $342,114 and paid $264,394; for 2,914 services of 28 kinds; $8,563 of it was for drugs given in the office and $255,831 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 468 | 2,914 | 77 | 0.92 | $1,287,998 | $264,394 |
| 2023 | 487 | 2,773 | 77 | 0.99 | $1,343,360 | $287,266 |
| 2022 | 515 | 2,340 | 76 | 0.93 | $1,174,604 | $264,655 |
| 2021 | 459 | 2,562 | 77 | 1.03 | $1,219,676 | $282,828 |
| 2020 | 405 | 1,722 | 77 | 1.10 | $918,049 | $201,322 |
| 2019 | 499 | 1,687 | 76 | 1.06 | $1,276,988 | $274,954 |
| 2018 | 546 | 1,880 | 76 | 1.07 | $1,144,571 | $246,778 |
| 2017 | 452 | 1,687 | 75 | 1.12 | $956,559 | $211,363 |
| 2016 | 469 | 1,622 | 75 | 1.07 | $936,762 | $209,896 |
| 2015 | 493 | 1,832 | 75 | 1.10 | $1,113,673 | $261,469 |
| 2014 | 413 | 1,398 | 75 | 1.05 | $895,593 | $199,581 |
| 2013 | 360 | 1,607 | 75 | 1.11 | $996,002 | $224,123 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Replacement of thigh bone and hip joint with prosthesis | 50 | $61,637 | $1,185 |
| Replacement of knee joint, both sides of knee | 49 | $60,525 | $1,187 |
| Return visit (30+ min) | 315 | $57,513 | $117 |
| Long return visit (40+ min) | 116 | $23,072 | $159 |
| New patient visit (45+ min) | 84 | $12,718 | $151 |
| Aspiration and/or injection of fluid from large joint | 114 | $11,830 | $72 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 49 | $9,656 | $189 |
| Injection of contrast for imaging of hip joint | 26 | $8,474 | $257 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 13 | $6,139 | None |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 55 | $4,906 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,678 | $153 |
| Short return visit (20+ min) | 14 | $1,148 | $82 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 108 | $565 | None |
2022: 14 services
| Replacement of thigh bone and hip joint with prosthesis | 47 | $56,479 | $1,177 |
| Return visit (30+ min) | 331 | $54,682 | $115 |
| Replacement of knee joint, both sides of knee | 39 | $48,352 | $1,179 |
| Long return visit (40+ min) | 122 | $24,646 | $162 |
| New patient visit (45+ min) | 106 | $15,797 | $149 |
| Aspiration and/or injection of fluid from large joint | 111 | $10,158 | $67 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 38 | $7,565 | $189 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 14 | $7,011 | None |
| Injection of contrast for imaging of hip joint | 20 | $5,647 | $269 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,235 | $181 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 47 | $4,152 | $87 |
| Short return visit (20+ min) | 19 | $1,364 | $72 |
| New patient visit (30+ min) | 13 | $1,273 | $98 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 110 | $249 | None |
2021: 15 services
| Return visit (30+ min) | 304 | $56,753 | $121 |
| Replacement of knee joint, both sides of knee | 38 | $47,140 | $1,209 |
| Replacement of thigh bone and hip joint with prosthesis | 36 | $42,434 | $1,179 |
| Long return visit (40+ min) | 91 | $19,708 | $168 |
| Aspiration and/or injection of fluid from large joint | 130 | $12,247 | $67 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 22 | $9,721 | None |
| New patient visit (45+ min) | 57 | $8,993 | $158 |
| Short return visit (20+ min) | 75 | $7,077 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,034 | $180 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 26 | $4,952 | $190 |
| Injection of contrast for imaging of hip joint | 15 | $4,413 | $260 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 31 | $2,732 | $88 |
| New patient visit (30+ min) | 23 | $2,526 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,095 | $95 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 117 | $181 | None |
2020: 12 services
| Replacement of knee joint, both sides of knee | 30 | $39,304 | $1,268 |
| Return visit (30+ min) | 269 | $38,667 | $96 |
| Replacement of thigh bone and hip joint with prosthesis | 21 | $26,960 | $1,284 |
| Long return visit (40+ min) | 91 | $15,841 | $132 |
| Aspiration and/or injection of fluid from large joint | 117 | $12,549 | $65 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 19 | $9,622 | None |
| Injection of contrast for imaging of hip joint | 20 | $6,175 | $229 |
| New patient visit (45+ min) | 35 | $4,840 | $138 |
| Short return visit (20+ min) | 55 | $3,882 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,641 | $182 |
| New patient visit (30+ min) | 25 | $2,034 | $81 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 115 | $227 | None |
2019: 13 services
| Replacement of knee joint, both sides of knee | 52 | $69,496 | $1,241 |
| Return visit (30+ min) | 337 | $49,121 | $94 |
| Replacement of thigh bone and hip joint with prosthesis | 33 | $41,705 | $1,227 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 12 | $13,726 | None |
| Long return visit (40+ min) | 90 | $13,573 | $126 |
| Aspiration and/or injection of fluid from large joint | 131 | $12,465 | $60 |
| Short return visit (20+ min) | 117 | $8,515 | $59 |
| Computer-assisted surgery for muscle and bone procedure | 52 | $7,267 | $132 |
| New patient visit (45+ min) | 46 | $6,661 | $145 |
| Injection of contrast for imaging of hip joint | 21 | $4,794 | $208 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,422 | $184 |
| New patient visit (30+ min) | 19 | $1,752 | $92 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 132 | $331 | None |
2018: 12 services
| Replacement of knee joint, both sides of knee | 44 | $53,682 | $1,220 |
| Return visit (30+ min) | 332 | $47,094 | $91 |
| Replacement of thigh bone and hip joint with prosthesis | 28 | $33,979 | $1,214 |
| Short return visit (20+ min) | 190 | $15,343 | $61 |
| Aspiration and/or injection of fluid from large joint | 156 | $14,955 | $58 |
| Long return visit (40+ min) | 75 | $11,060 | $129 |
| New patient visit (45+ min) | 41 | $5,870 | $143 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 11 | $5,855 | None |
| Injection of contrast for imaging of hip joint | 25 | $5,656 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,640 | $182 |
| New patient visit (30+ min) | 39 | $3,426 | $88 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 156 | $537 | None |
2017: 12 services
| Replacement of knee joint, both sides of knee | 34 | $44,067 | $1,224 |
| Return visit (30+ min) | 283 | $42,419 | $89 |
| Replacement of thigh bone and hip joint with prosthesis | 21 | $26,664 | $1,212 |
| Short return visit (20+ min) | 204 | $15,579 | $59 |
| Aspiration and/or injection of fluid from large joint | 147 | $14,920 | $58 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 22 | $8,406 | None |
| Long return visit (40+ min) | 59 | $8,070 | $124 |
| Injection of contrast for imaging of hip joint | 24 | $5,570 | $192 |
| New patient visit (45+ min) | 28 | $3,756 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,445 | $181 |
| New patient visit (30+ min) | 26 | $2,553 | $98 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 152 | $464 | None |
2016: 12 services
| Replacement of knee joint, both sides of knee | 32 | $42,763 | $1,222 |
| Return visit (30+ min) | 269 | $41,453 | $93 |
| Replacement of thigh bone and hip joint with prosthesis | 19 | $23,221 | $1,222 |
| Short return visit (20+ min) | 193 | $15,483 | $58 |
| Aspiration and/or injection of fluid from large joint | 142 | $13,264 | $59 |
| Long return visit (40+ min) | 56 | $7,198 | $120 |
| Injection of contrast for imaging of hip joint | 29 | $6,862 | $202 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 18 | $6,223 | None |
| New patient visit (45+ min) | 28 | $4,257 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,966 | $180 |
| New patient visit (30+ min) | 30 | $2,727 | $91 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 150 | $477 | None |
2015: 12 services
| Replacement of knee joint, both sides of knee | 45 | $60,315 | $1,283 |
| Return visit (30+ min) | 320 | $50,920 | $97 |
| Replacement of thigh bone and hip joint with prosthesis | 20 | $25,606 | $1,280 |
| Aspiration and/or injection of fluid from large joint | 149 | $17,469 | $63 |
| Short return visit (20+ min) | 188 | $17,250 | $67 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 26 | $9,277 | None |
| Injection of contrast for imaging of hip joint | 35 | $8,777 | $199 |
| Long return visit (40+ min) | 53 | $8,312 | $139 |
| New patient visit (45+ min) | 29 | $4,510 | $156 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,977 | $189 |
| New patient visit (30+ min) | 35 | $3,502 | $100 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 156 | $485 | None |
2014: 11 services
| Return visit (30+ min) | 330 | $52,632 | $90 |
| Replacement of knee joint, both sides of knee | 35 | $45,157 | $1,220 |
| Replacement of thigh bone and hip joint with prosthesis | 16 | $20,404 | $1,200 |
| Aspiration and/or injection of fluid from large joint | 121 | $11,439 | $51 |
| Short return visit (20+ min) | 79 | $5,966 | $64 |
| New patient visit (45+ min) | 31 | $4,510 | $145 |
| Long return visit (40+ min) | 35 | $4,459 | $124 |
| Injection of contrast for imaging of hip joint | 17 | $3,712 | $186 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,158 | $180 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 17 | $2,070 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 118 | $268 | None |
2013: 10 services
| Replacement of knee joint, both sides of knee | 34 | $51,092 | $1,381 |
| Return visit (30+ min) | 279 | $48,972 | $93 |
| Replacement of thigh bone and hip joint with prosthesis | 15 | $19,391 | $1,293 |
| Aspiration and/or injection of fluid from large joint | 128 | $15,935 | $48 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 36 | $7,755 | None |
| Short return visit (20+ min) | 95 | $7,734 | $62 |
| New patient visit (45+ min) | 39 | $5,837 | $150 |
| Injection of contrast for imaging of hip joint | 20 | $3,887 | $194 |
| Long return visit (40+ min) | 20 | $2,652 | $133 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 122 | $318 | None |
Medicaid work
$978 in 2019
Medicaid paid $978 for 15 billed services this clinician did in 2019, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 15 | $978 |
| 2019 | 15 | 1 | 15 | $978 |
Drugs they prescribed that Part D paid
$9,973
Pharmacies billed $9,973 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 14% of their Part D prescriptions (98 of 697) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
689 generic and fewer than 11 brand-name prescriptions · $9,973 in drug cost · 196 antibiotic prescriptions to 150 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 118 | $5,564 | $47 |
| Meloxicam | 183 | $840 | $5 |
| Gabapentin | 24 | $566 | $24 |
| Hydrocodone-Acetaminophen | 41 | $517 | $13 |
| Amoxicillin | 132 | $404 | $3 |
See all 13 drugs
| Celecoxib | 118 | $5,564 | $47 |
| Meloxicam | 183 | $840 | $5 |
| Gabapentin | 24 | $566 | $24 |
| Hydrocodone-Acetaminophen | 41 | $517 | $13 |
| Amoxicillin | 132 | $404 | $3 |
| Cephalexin | 14 | $385 | $27 |
| Nitrofurantoin Mono-Macro | 12 | $272 | $23 |
| Oxycodone-Acetaminophen | 11 | $216 | $20 |
| Oxycodone | 22 | $182 | $8 |
| Clindamycin | 31 | $124 | $4 |
| Ibuprofen | 15 | $112 | $7 |
| Prednisone | 15 | $87 | $6 |
| Tramadol | 14 | $44 | $3 |
Year by year
| 2024 | 697 | 239 | 14% (98) | None | $9,973 |
| 2023 | 664 | 248 | 14% (94) | None | $11,962 |
| 2022 | 560 | 207 | 19% (104) | None | $13,114 |
| 2021 | 605 | 193 | 22% (131) | None | $13,290 |
| 2020 | 636 | 188 | 30% (189) | 2% | $15,733 |
| 2019 | 727 | 209 | 38% (278) | 3% | $25,221 |
| 2018 | 768 | 217 | 39% (301) | 3% | $25,779 |
| 2017 | 883 | 222 | 42% (367) | 3% | $36,246 |
| 2016 | 984 | 220 | 46% (452) | 2% | $50,560 |
| 2015 | 1,046 | 230 | 48% (506) | 6% | $63,872 |
| 2014 | 919 | 183 | 55% (508) | 8% | $63,562 |
| 2013 | 829 | 169 | 55% (454) | 7% | $48,712 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Celecoxib | 90 | $5,563 | $62 |
| Cephalexin | 16 | $1,439 | $90 |
| Meloxicam | 144 | $745 | $5 |
| Gabapentin | 29 | $734 | $25 |
| Amoxicillin | 158 | $529 | $3 |
| Hydrocodone-Acetaminophen | 13 | $421 | $32 |
| Oxycodone | 39 | $409 | $10 |
| Clindamycin | 38 | $213 | $6 |
| Tramadol | 26 | $192 | $7 |
| Ibuprofen | 18 | $141 | $8 |
| Prednisone | 14 | $53 | $4 |
2022: 12 drugs
| Celecoxib | 58 | $5,477 | $94 |
| Hydrocodone-Acetaminophen | 43 | $1,347 | $31 |
| Fentanyl | 11 | $1,085 | $99 |
| Meloxicam | 121 | $890 | $7 |
| Gabapentin | 28 | $669 | $24 |
| Oxycodone-Acetaminophen | 22 | $662 | $30 |
| Amoxicillin | 123 | $424 | $3 |
| Ibuprofen | 16 | $133 | $8 |
| Sulfamethoxazole-Trimethoprim | 11 | $125 | $11 |
| Clindamycin | 25 | $125 | $5 |
| Methocarbamol | 13 | $112 | $9 |
| Tramadol | 20 | $97 | $5 |
2021: 15 drugs
| Celecoxib | 43 | $3,267 | $76 |
| Hydrocodone-Acetaminophen | 60 | $1,782 | $30 |
| Gabapentin | 59 | $1,299 | $22 |
| Oxycodone-Acetaminophen | 25 | $926 | $37 |
| Fentanyl | 12 | $925 | $77 |
| Nitrofurantoin Mono-Macro | 12 | $910 | $76 |
| Oxycodone | 12 | $829 | $69 |
| Meloxicam | 108 | $620 | $6 |
| Diclofenac | 24 | $494 | $21 |
| Amoxicillin | 113 | $408 | $4 |
| Methocarbamol | 12 | $169 | $14 |
| Ibuprofen | 15 | $129 | $9 |
| Clindamycin | 29 | $126 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $94 | $8 |
| Tramadol | 12 | $67 | $6 |
2020: 15 drugs
| Hydrocodone-Acetaminophen | 108 | $3,583 | $33 |
| Celecoxib | 36 | $2,770 | $77 |
| Gabapentin | 71 | $1,743 | $25 |
| Oxycodone-Acetaminophen | 28 | $1,429 | $51 |
| Diclofenac | 25 | $1,110 | $44 |
| Fentanyl | 12 | $925 | $77 |
| Meloxicam | 95 | $702 | $7 |
| Oxycodone | 14 | $625 | $45 |
| Nitrofurantoin Mono-Macro | 16 | $354 | $22 |
| Amoxicillin | 79 | $265 | $3 |
| Clindamycin | 47 | $221 | $5 |
| Methocarbamol | 12 | $179 | $15 |
| Tramadol | 17 | $110 | $6 |
| Ibuprofen | 13 | $108 | $8 |
| Promethazine | 12 | $91 | $8 |
2019: 14 drugs
| Hydrocodone-Acetaminophen | 139 | $4,647 | $33 |
| Celecoxib | 44 | $2,882 | $66 |
| Oxycodone-Acetaminophen | 53 | $2,665 | $50 |
| Gabapentin | 78 | $2,458 | $32 |
| Diclofenac | 25 | $1,376 | $55 |
| Fentanyl | 12 | $925 | $77 |
| Oxycodone | 20 | $562 | $28 |
| Meloxicam | 82 | $551 | $7 |
| Amoxicillin | 86 | $371 | $4 |
| Acetaminophen-Codeine | 15 | $328 | $22 |
| Methocarbamol | 13 | $218 | $17 |
| Tramadol | 23 | $204 | $9 |
| Clindamycin | 30 | $152 | $5 |
| Prednisone | 11 | $68 | $6 |
2018: 17 drugs
| Hydrocodone-Acetaminophen | 176 | $8,363 | $48 |
| Oxycodone-Acetaminophen | 44 | $3,272 | $74 |
| Celecoxib | 39 | $2,659 | $68 |
| Voltaren | 16 | $2,303 | $144 |
| Gabapentin | 72 | $2,127 | $30 |
| Diclofenac | 29 | $1,326 | $46 |
| Fentanyl | 11 | $854 | $78 |
| Morphine Sulfate Er | 21 | $666 | $32 |
| Meloxicam | 113 | $541 | $5 |
| Amoxicillin | 85 | $378 | $4 |
| Tramadol | 20 | $319 | $16 |
| Acetaminophen-Codeine | 17 | $300 | $18 |
| Oxycodone | 12 | $267 | $22 |
| Methocarbamol | 12 | $229 | $19 |
| Clindamycin | 24 | $105 | $4 |
| Cyclobenzaprine | 18 | $83 | $5 |
| Prednisone | 11 | $51 | $5 |
2017: 18 drugs
| Oxycodone-Acetaminophen | 56 | $5,891 | $105 |
| Hydrocodone-Acetaminophen | 188 | $5,743 | $31 |
| Celecoxib | 46 | $4,887 | $106 |
| Gabapentin | 76 | $2,404 | $32 |
| Fentanyl | 18 | $2,098 | $117 |
| Voltaren | 18 | $2,058 | $114 |
| Morphine Sulfate Er | 36 | $1,825 | $51 |
| Piroxicam | 12 | $1,121 | $93 |
| Oxycodone | 18 | $815 | $45 |
| Meloxicam | 101 | $540 | $5 |
| Diclofenac | 15 | $492 | $33 |
| Amoxicillin | 107 | $487 | $5 |
| Acetaminophen-Codeine | 21 | $462 | $22 |
| Tramadol | 27 | $333 | $12 |
| Methocarbamol | 11 | $175 | $16 |
| Prednisone | 17 | $106 | $6 |
| Clindamycin | 17 | $81 | $5 |
| Cyclobenzaprine | 19 | $53 | $3 |
2016: 20 drugs
| Oxycodone-Acetaminophen | 90 | $11,787 | $131 |
| Hydrocodone-Acetaminophen | 206 | $11,377 | $55 |
| Celecoxib | 38 | $4,976 | $131 |
| Morphine Sulfate Er | 42 | $2,877 | $69 |
| Gabapentin | 80 | $2,720 | $34 |
| Fentanyl | 31 | $2,614 | $84 |
| Lidocaine | 18 | $1,713 | $95 |
| Oxycodone | 24 | $1,472 | $61 |
| Acetaminophen-Codeine | 22 | $829 | $38 |
| Diclofenac | 17 | $765 | $45 |
| Meloxicam | 109 | $510 | $5 |
| Piroxicam | 12 | $426 | $35 |
| Tramadol | 31 | $390 | $13 |
| Amoxicillin | 58 | $263 | $5 |
| Nortriptyline | 16 | $220 | $14 |
| Methocarbamol | 13 | $209 | $16 |
| Clindamycin | 22 | $162 | $7 |
| Prednisone | 26 | $126 | $5 |
| Temazepam | 15 | $115 | $8 |
| Cyclobenzaprine | 18 | $74 | $4 |
2015: 21 drugs
| Hydrocodone-Acetaminophen | 245 | $12,809 | $52 |
| Oxycodone-Acetaminophen | 78 | $12,012 | $154 |
| Celecoxib | 40 | $8,275 | $207 |
| Fentanyl | 43 | $3,638 | $85 |
| Lyrica | 11 | $3,485 | $317 |
| Morphine Sulfate Er | 47 | $3,145 | $67 |
| Gabapentin | 82 | $2,402 | $29 |
| Oxycodone | 31 | $1,673 | $54 |
| Lidocaine | 11 | $1,587 | $144 |
| Acetaminophen-Codeine | 28 | $952 | $34 |
| Diclofenac | 20 | $565 | $28 |
| Piroxicam | 13 | $453 | $35 |
| Meloxicam | 113 | $432 | $4 |
| Amoxicillin | 74 | $278 | $4 |
| Tramadol | 22 | $226 | $10 |
| Methocarbamol | 12 | $188 | $16 |
| Cyclobenzaprine | 14 | $142 | $10 |
| Nortriptyline | 15 | $136 | $9 |
| Clindamycin | 22 | $113 | $5 |
| Prednisone | 18 | $99 | $5 |
| Lorazepam | 13 | $16 | $1 |
2014: 19 drugs
| Celebrex | 31 | $15,477 | $499 |
| Hydrocodone-Acetaminophen | 265 | $10,908 | $41 |
| Oxycodone-Acetaminophen | 42 | $7,165 | $171 |
| Oxycontin | 15 | $4,909 | $327 |
| Morphine Sulfate Er | 42 | $3,914 | $93 |
| Fentanyl | 28 | $3,216 | $115 |
| Gabapentin | 77 | $3,087 | $40 |
| Oxycodone | 34 | $1,702 | $50 |
| Voltaren | 12 | $1,481 | $123 |
| Acetaminophen-Codeine | 42 | $1,032 | $25 |
| Diclofenac | 33 | $838 | $25 |
| Piroxicam | 15 | $517 | $34 |
| Tramadol | 28 | $461 | $16 |
| Amoxicillin | 53 | $232 | $4 |
| Methocarbamol | 13 | $218 | $17 |
| Nortriptyline | 16 | $211 | $13 |
| Meloxicam | 41 | $207 | $5 |
| Cephalexin | 12 | $154 | $13 |
| Clindamycin | 25 | $146 | $6 |
2013: 19 drugs
| Celebrex | 19 | $9,712 | $511 |
| Hydrocodone-Acetaminophen | 289 | $9,445 | $33 |
| Lidoderm | 20 | $6,181 | $309 |
| Oxycodone Hcl-Acetaminophen | 27 | $3,288 | $122 |
| Fentanyl | 19 | $3,270 | $172 |
| Gabapentin | 57 | $3,199 | $56 |
| Morphine Sulfate Er | 25 | $1,700 | $68 |
| Oxycodone | 27 | $1,222 | $45 |
| Acetaminophen-Codeine | 39 | $893 | $23 |
| Diclofenac | 20 | $783 | $39 |
| Tramadol | 23 | $523 | $23 |
| Piroxicam | 13 | $471 | $36 |
| Amoxicillin | 53 | $243 | $5 |
| Methocarbamol | 13 | $237 | $18 |
| Cyclobenzaprine | 22 | $202 | $9 |
| Cephalexin | 11 | $148 | $13 |
| Meloxicam | 22 | $111 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $100 | $9 |
| Prednisone | 12 | $51 | $4 |
Money from drug and device companies
$331 in 2025
| 2025 | 3 | 7 | None | $331 |
| 2023 | 1 | 9 | None | $1,119 |
| 2022 | 1 | 2 | None | $41 |
| 2021 | 2 | 2 | None | $152 |
| 2019 | 1 | 3 | None | $96 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Insignia | $292 | 5 payments
|
| Medtronic | Aquamantys(Tm) | $22 | 1 payment
|
| Bioventus | Durolane | $17 | 1 payment
|
See all 7 published payments
| Stryker | Meals · 2025-12-12 | Tbcem | $32 |
| Stryker | Meals · 2025-11-12 | Insignia | $63 |
| Stryker | Meals · 2025-11-12 | None | $31 |
| Medtronic | Meals · 2025-11-05 | Aquamantys(Tm) | $22 |
| Stryker | Meals · 2025-04-14 | Insignia | $134 |
| Stryker | Meals · 2025-03-17 | Trident | $33 |
| Bioventus | Meals · 2025-03-12 | Durolane | $17 |
See earlier years (2023, 2022, 2021, 2019)
2023: $1,119
| Stryker | Mako | $1,119 | 9 payments
|
2022: $41
| Heraeus Medical | Palacos | $41 | 2 payments
|
2021: $152
| DePuy Synthes Sales | None | $134 | 1 payment
|
| Medical Device Business Services | Velys | $18 | 1 payment
|
2019: $96
| Stryker | Mako | $96 | 3 payments
|
Professional record
- NPI
- 1720169352
- Licence
- CA G37699California G37699: Current · expires 2028-05-31
- Trained
- Boston University School of Medicine, 1977
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-10-18
- NPI last updated
- 2011-12-06
This is when the NPI record was last certified, not a medical board exam.